Written July 29, 2025, 14:45 EDT

UnitedHealth Group Inc., one of the largest health care and insurance providers in the U.S., reported weaker-than-expected earnings for the second quarter of 2025 and released a cautious outlook for the coming year. The company pointed to surging medical expenses and ongoing industry-wide cost pressures as key factors driving its underperformance and lowered guidance.

Second-quarter earnings fall short of Wall Street expectations

In its Q2 financial report released Tuesday, UnitedHealth said it earned $4.08 per share in adjusted earnings on $111.6 billion in revenue. Analysts surveyed by FactSet had projected higher earnings of $4.48 per share, although revenue came in slightly above expectations.

While revenue rose 13% year-over-year, net profit dropped 19% to $3.41 billion, largely due to a sharp increase in health care costs. UnitedHealth reported a 20% surge in medical expenses, totaling $78.6 billion—its largest category of spending.

This performance has reinforced investor concerns about the growing pressure on health insurers as medical costs rise faster than premium adjustments can keep pace.

Medical costs climb across the insurance industry

The earnings disappointment from UnitedHealth follows a trend among major U.S. health insurers. Rivals such as Elevance Health Inc. and Centene Corp. have also revised their annual forecasts downward in response to similar challenges, citing unexpected increases in costs related to emergency care, behavioral health services, and cutting-edge treatments like gene therapies and oncology medications.

UnitedHealth’s executives acknowledged that the company miscalculated the rate at which care activity would rebound following pandemic-related slowdowns.

“We underestimated care activity and cost trends,” said Chairman and acting CEO Stephen Hemsley. “While these pressures remain, we are implementing corrective actions and expect stabilization over the longer term.”

2025 outlook cut sharply, long-term growth expected in 2026

UnitedHealth had originally forecasted adjusted earnings of up to $30 per share for 2025, but withdrew that guidance in May following cost concerns and leadership changes. In Tuesday’s update, the company issued a new, more conservative outlook of at least $16 per share in adjusted earnings for 2025—almost half the original expectation.

Analysts, by comparison, are currently forecasting $20.64 per share for the full year, according to FactSet.

Despite this downward revision, UnitedHealth remains optimistic about longer-term performance. The company stated that it anticipates a return to earnings growth by 2026, assuming cost-control efforts and operational improvements take effect.

Leadership changes and earlier stock shock

The company’s financial troubles have been accompanied by executive upheaval. In May, CEO Andrew Witty abruptly stepped down, triggering uncertainty across the industry. He was replaced by Stephen Hemsley, UnitedHealth’s former long-time CEO who now holds both the Chairman and acting CEO roles.

In April, UnitedHealth had already taken the unusual step of cutting its forecast mid-year, which triggered a dramatic one-day decline in its share price—dropping $130 in a single session, the company’s worst performance in over 25 years.

UnitedHealth stock under pressure in 2025

Investor reaction to the Q2 report was swift. UnitedHealth shares fell more than 3%, trading at around $272.30 before Tuesday’s market open.

This marks a dramatic downturn from the company’s all-time high of over $630 per share reached in November 2024. Since then, shares have plummeted 44% year-to-date, reflecting both investor concern and broader market reactions to developments within the company.

For comparison, the Dow Jones Industrial Average, of which UnitedHealth is a component, has gained 5% over the same period—highlighting the company’s divergence from the broader market trend.

The stock’s decline also follows the December 2024 fatal shooting of UnitedHealthcare CEO Brian Thompson in midtown Manhattan, which occurred just hours before the company’s annual investor meeting. While not directly tied to financial performance, the incident marked a period of turbulence and instability for the insurer.

Optum remains a key growth driver

UnitedHealth continues to lean on its Optum division, which includes pharmacy benefit management (PBM), health care delivery, and technology services. The unit has shown steady revenue growth and remains central to the company’s long-term strategy.

Despite current headwinds, executives say Optum’s integration of technology and data-driven care models positions the company to adapt to rising medical costs more efficiently than competitors.

Still, the company faces an uphill battle in regaining investor confidence, particularly if costs continue to rise faster than expected or reimbursement models fail to adjust accordingly.

Industry-wide implications and regulatory outlook

UnitedHealth’s latest results come amid growing scrutiny of health insurance profitability and coverage adequacy in the U.S. Lawmakers and consumer advocates have raised concerns over whether private insurers are prepared to manage increasing demand for behavioral health services, expensive specialty drugs, and the rising prevalence of chronic illnesses.

Additionally, regulatory reforms aimed at increasing pricing transparency and simplifying prior authorization processes may further impact margins in the coming years.

Looking ahead

Despite a weak earnings quarter and a downgraded forecast, UnitedHealth insists that its long-term fundamentals remain strong. Leadership has promised continued investment in care quality, efficiency improvements, and cost containment strategies.

“We are taking prudent steps to stabilize performance,” said Hemsley. “The actions underway will help ensure long-term resilience in a complex health care landscape.”

Investors, however, may continue to tread cautiously as the company works through its cost challenges and leadership transition.

Source: AP News – UnitedHealth falls short of second quarter expectations and offers weak outlook for 2025

The post UnitedHealth earnings miss Q2 estimates, issues weak 2025 forecast appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.

New York police have released two photos of an unmasked man wanted for questioning in the killing of Brian Thompson, the 50-year-old CEO of UnitedHealthcare.

Thompson was fatally shot in the back on Wednesday morning outside the Hilton hotel in Midtown Manhattan. The suspect fled the scene without stealing any of Thompson’s belongings, leading investigators to believe the killing was premeditated.

Authorities are using facial recognition technology and analyzing bullet casings marked with cryptic messages to track down the killer. So far, no motive has been confirmed.

Details of the Attack and Escape

The shooting occurred at 6:45 a.m. near Times Square and Central Park. Thompson was on his way to deliver a speech at an investor conference later that day.

The suspect, wearing a black face mask and a cream-colored jacket, appeared to have waited outside the Hilton hotel for five minutes before the attack. CCTV footage shows the suspect used a pistol equipped with a suppressor. NYPD Chief of Detectives Joseph Kenny revealed that the weapon jammed during the shooting, but the assailant managed to fix it and continue firing.

Thompson was shot in the back and leg. He was pronounced dead at a nearby hospital about 30 minutes later.

After the attack, the suspect fled on foot. Initial reports suggested he used an electric Citi Bike, but Lyft, which operates Citi Bike, later confirmed that no such vehicle was involved.

Key Clues in the Investigation

The investigation has focused on several critical pieces of evidence:

1. Suspect Photos and Video:
   • Two images of an unmasked man believed to be connected to the crime were released.
   • Surveillance footage shows the suspect at a Starbucks shortly before the shooting. The mask partially revealed his face, allowing investigators to use facial recognition software.
2. Bullet Casings with Messages:
   • Three bullet casings at the scene were marked with the words “deny,” “defend,” and “depose.”
   • These terms are associated with criticism of the insurance industry’s tactics to reject claims.
3. Recovered Items:
   • A discarded coffee cup, potentially carrying fingerprints, has been sent for analysis.
   • A mobile phone found along the escape route is being examined.
4. Surveillance and Travel Details:
   • The suspect reportedly took a bus from Atlanta, Georgia, to New York days before the shooting, though it’s unclear if he boarded in Atlanta or during a stop.
   • Video shows him outside a residence near the Frederick Douglas housing project on the Upper West Side around 5:00 a.m. on the day of the crime.

The Victim: Brian Thompson

Thompson joined UnitedHealthcare in 2004 and became CEO in 2021, leading the company through a highly profitable period.

His wife told reporters that Thompson had previously received threats but could not provide specific details. Police in his hometown of Maple Grove, Minnesota, confirmed a suspicious incident at his home in 2018, though no criminal activity was identified.

What’s Next in the Case

The NYPD has intensified its efforts, including:

• Searching Thompson’s hotel room for additional clues.
• Visiting gun stores in Connecticut to trace the suspect’s firearm, which may have military origins.
• Testing DNA from evidence like the coffee cup and bullet casings.

While investigators are still piecing together the motive, the details suggest a carefully orchestrated act. The cryptic clues left behind may hold the key to understanding why Thompson was targeted.

Source

The post Police Release New Photos in Hunt for CEO’s Killer appeared first on Journos News - Breaking News, World News, Top Stories, Todays Headlines and Flash Reports.